Jones Trading Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $135
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
Jones Trading analyst Catherine Novack initiates coverage on Spruce Biosciences (NASDAQ:SPRB) with a Buy rating and announces Price Target of $135.
Jones Trading analyst Catherine Novack initiates coverage on Spruce Biosciences (NASDAQ:SPRB) with a Buy rating and announces Price Target of $135.